GeneDx Holdings Corp
NASDAQ:WGS
GeneDx Holdings Corp
NASDAQ:WGS
Price:
21.16 USD
-0.89%
Market Closed
Updated:
May 16, 2024
Section:
Relative Value
The Relative Value of one
WGS
stock under the Base Case scenario is
14.35
USD.
Compared to the current market price of 21.16 USD,
GeneDx Holdings Corp
is
Overvalued by 32%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
WGS
Relative Value
Base Case
14.35
USD
Overvaluation 32%
Valuation Multiples
Multiples Across Competitors
WGS Competitors Multiples
GeneDx Holdings Corp Competitors
GeneDx Holdings Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
GeneDx Holdings Corp
NASDAQ:WGS
|
552.7m USD | 2.5 | -4.1 | -5.2 | -3.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
91.5B EUR | 0.5 | 27.5 | 9.9 | 13.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
97.6B USD | 0.5 | 27 | 9.7 | 12.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
70.4B USD | 0.2 | 9.6 | 8.7 | 8.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
18B USD | 1.5 | 41.5 | 12.5 | 18.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.2B EUR | 0.7 | -27.2 | 10.3 | 22.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.6B USD | 1.7 | 18.6 | 11 | 14.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12.3B EUR | 0.6 | 24.7 | 7.1 | 16.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
12B EUR | 0.6 | 24 | 7 | 16.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.1B USD | 1 | 14.8 | 8.3 | 11.9 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
